A study elucidated a potential mechanism for glioma recurrence in which normal glioma-associated astrocytes protected MGMT negative glioma cells from temozolomide (TMZ)-induced apoptosis by transferring EVs MGMT mRNA [87]. This evidence concerns the gene MGMT and central nervous system cancer.